Article
Greg Foltz, MD, Director, Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, WA, discusses current treatments for brain cancer.
Advancing the Diagnostic Criteria for Multiple Sclerosis: A New Era of Early Detection and Precision
Rare Disease Report Podcast: CDKL5 Deficiency Disorder Expert Interview
FDA Approves Eplontersen (Wainua) for ATTRv Polyneuropathy
The Rare Disease Report Podcast: Adrenomyeloneuropathy
Changes in the Diagnostic Process of Alzheimer Disease: A New Era of Blood-Based Approaches
After Elevidys: DMD Advocacy Past First Gene Therapy Approval